South Beach Symposium CEO interview

Dr. Mark Nestor, MD,  Medical Director & President of South Beach Symposium and President of the American Cutaneous Oncology Society (ACOS), recently interviewed Sensus Healthcare’s CEO, Joe Sardano. The interview occurred last week as a virtual lead-in to February’s Symposium.  In it, Mr. Sardano discusses the treatment of non-melanoma skin cancer patients with SRT during the COVID-19 pandemic, the prospect of increased reimbursement for SRT and the opportunities provided and plans for growth with the company’s newly acquired mobile laser business.

 

 

 

Share this article

The Benefits of SRT

Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:

98.7%+
Non Reoccurrence Rate

No anesthesia, cutting, bleeding, stitching or pain

No downtime or lifestyle restrictions

Super cosmesis, no unsightly scarring

No need for post-treatment reconstructive surgeries

Patient Inquiry

Patient Inquiry

Discover how Sensus Healthcare and the SRT-100TM are removing the physical and emotional pain often associated with skin cancer treatment.
LEARN MORE

Physician Inquiry

Physician Inquiry

Discover how Sensus Healthcare and the SRT-100TM are removing the physical and emotional pain often associated with skin cancer treatment.
LEARN MORE

General Inquiry

General Inquiry

Discover how Sensus Healthcare and the SRT-100TM are removing the physical and emotional pain often associated with skin cancer treatment.
LEARN MORE